Heparin-coated cardiopulmonary bypass circuits: current status.
about
A new practical technique to reduce allogeneic blood exposure and hospital costs while preserving clotting factors after cardiopulmonary bypass: the HemobagHeparin promotes platelet responsiveness by potentiating αIIbβ3-mediated outside-in signaling.Is hyperoxaemia helping or hurting patients during extracorporeal membrane oxygenation? Review of a complex problem.Use of extracorporeal membrane oxygenation in tracheal surgery: a case series.Surface modification and endothelialization of biomaterials as potential scaffolds for vascular tissue engineering applications.Capabilities of a mobile extracorporeal membrane oxygenation service for severe respiratory failure delivered by intensive care specialists.Pharmacological profiles of animal- and nonanimal-derived sulfated polysaccharides--comparison of unfractionated heparin, the semisynthetic glucan sulfate PS3, and the sulfated polysaccharide fraction isolated from Delesseria sanguinea.The impact of different biocompatible coated cardiopulmonary bypass circuits on inflammatory response and oxidative stress.Recent advances in biocompatible surface-modifying additives for cardiopulmonary bypass.Current Strategies in Cardiovascular Biomaterial Functionalization.Effect of biopassive and bioactive surface-coatings on the hemocompatibility of membrane oxygenators.Comparison of a Duraflo II-coated cardiopulmonary bypass circuit and a trillium-coated oxygenator during open-heart surgery.
P2860
Q28287592-889313C8-CC5F-425B-AECD-BD6B80162ABBQ35001659-769A98D2-F25D-4544-B705-9E9C4B36AF34Q38074386-DB619C40-3C41-46A3-88AA-3886822E72F1Q38127538-AA4AAC5D-ECDA-4C68-A7B7-5B2803614852Q38507265-5C29CBFD-3FE1-4BC4-9154-6D508BF2CB0FQ41104479-4AAADEC0-83E7-4BEA-953D-A8598BF928E8Q43171467-1C141CA9-2D5B-4047-B60C-94FD7554BF8CQ43254535-42127CE5-F5CF-41B9-9C94-3A1FA22FC144Q44412436-5DA3D170-6BDB-424B-859F-F3EDBF9D20D4Q47162762-83E33DCD-8A91-497F-9F34-E5E6ED6BEFB2Q51161526-2754645B-D72E-4540-B845-A5BA6FC4D11FQ51634558-54CF4AEF-CCF2-437F-B006-A2D0C7B560FB
P2860
Heparin-coated cardiopulmonary bypass circuits: current status.
description
2001 nî lūn-bûn
@nan
2001 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Heparin-coated cardiopulmonary bypass circuits: current status.
@ast
Heparin-coated cardiopulmonary bypass circuits: current status.
@en
Heparin-coated cardiopulmonary bypass circuits: current status.
@nl
type
label
Heparin-coated cardiopulmonary bypass circuits: current status.
@ast
Heparin-coated cardiopulmonary bypass circuits: current status.
@en
Heparin-coated cardiopulmonary bypass circuits: current status.
@nl
prefLabel
Heparin-coated cardiopulmonary bypass circuits: current status.
@ast
Heparin-coated cardiopulmonary bypass circuits: current status.
@en
Heparin-coated cardiopulmonary bypass circuits: current status.
@nl
P2860
P1433
P1476
Heparin-coated cardiopulmonary bypass circuits: current status.
@en
P2093
P2860
P304
P356
10.1177/026765910101600512
P577
2001-09-01T00:00:00Z